[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MX345485B - Equibiotic compositions and methods for treating periodontal disease and halitosis in animals. - Google Patents

Equibiotic compositions and methods for treating periodontal disease and halitosis in animals.

Info

Publication number
MX345485B
MX345485B MX2012014315A MX2012014315A MX345485B MX 345485 B MX345485 B MX 345485B MX 2012014315 A MX2012014315 A MX 2012014315A MX 2012014315 A MX2012014315 A MX 2012014315A MX 345485 B MX345485 B MX 345485B
Authority
MX
Mexico
Prior art keywords
equibiotic
compositions
animals
halitosis
periodontal disease
Prior art date
Application number
MX2012014315A
Other languages
Spanish (es)
Other versions
MX2012014315A (en
Inventor
Lozoya Legorreta Xavier
Rivera Arce Erika
Agüero Agüero Juan
Faci Villalobos Patricia
Gascón Muro Marisela
Original Assignee
Lozoya Legorreta Xavier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lozoya Legorreta Xavier filed Critical Lozoya Legorreta Xavier
Priority to MX2012014315A priority Critical patent/MX345485B/en
Priority to PCT/IB2013/060715 priority patent/WO2014097044A1/en
Publication of MX2012014315A publication Critical patent/MX2012014315A/en
Publication of MX345485B publication Critical patent/MX345485B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/57—Magnoliaceae (Magnolia family)
    • A61K36/575—Magnolia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention describes equibiotic compositions effective for treating periodontal disease, gingivitis, and/or halitosis in animals for example, in domestic animals including dogs and cats, wherein the equibiotic compositions have synergistic antimicrobial activity and comprise standardized extracts of Psidii pumilum var. guadalupense (D.C.) and Houpoea officinalis (Rehder & E.H. Wilson). The compositions of the invention are equibiotic products, since they exhibit antimicrobial and/or antibiotic action against the microorganisms involved in periodontal disease and halitosis, while also at the same time restoring the equilibrium of oral microbiota in animals. The equibiotic compositions of the invention are unique in that their action influences and strengthens the immunological regulation of the host.
MX2012014315A 2012-12-07 2012-12-07 Equibiotic compositions and methods for treating periodontal disease and halitosis in animals. MX345485B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MX2012014315A MX345485B (en) 2012-12-07 2012-12-07 Equibiotic compositions and methods for treating periodontal disease and halitosis in animals.
PCT/IB2013/060715 WO2014097044A1 (en) 2012-12-07 2013-12-07 Equibiotic compositions and methods for treating periodontal disease and halitosis in animals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2012014315A MX345485B (en) 2012-12-07 2012-12-07 Equibiotic compositions and methods for treating periodontal disease and halitosis in animals.

Publications (2)

Publication Number Publication Date
MX2012014315A MX2012014315A (en) 2014-06-24
MX345485B true MX345485B (en) 2017-01-31

Family

ID=50977704

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012014315A MX345485B (en) 2012-12-07 2012-12-07 Equibiotic compositions and methods for treating periodontal disease and halitosis in animals.

Country Status (2)

Country Link
MX (1) MX345485B (en)
WO (1) WO2014097044A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201818627D0 (en) * 2018-11-15 2019-01-02 Mars Inc Analytical systems

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500409B1 (en) * 2000-05-10 2002-12-31 Colgate Palmolive Company Synergistic antiplaque/antigingivitis oral composition
US8900644B2 (en) * 2004-12-22 2014-12-02 Colgate-Palmolive Company Oral care compositions containing compounds from magnolia and hops extracts
US20060140885A1 (en) * 2004-12-29 2006-06-29 Abdul Gaffar Method of reducing oral tissue inflammation using magnolia extract
JP5523663B2 (en) * 2007-11-05 2014-06-18 和夫 永井 Pharmaceutical composition for promoting root-periodontal tissue formation
MX2008016471A (en) * 2008-12-19 2010-06-22 Genomma Lab Internac S A B De Immediate release oral compositions of magnolia for treating halitosis.
TWI459957B (en) * 2010-02-24 2014-11-11 Colgate Palmolive Co Oral care compositions

Also Published As

Publication number Publication date
WO2014097044A1 (en) 2014-06-26
MX2012014315A (en) 2014-06-24

Similar Documents

Publication Publication Date Title
PH12016502092A1 (en) Antimicrobial compounds and methods of making and using the same
PH12014502717A1 (en) Synergistic compositions for the protection of agrarian crops and the use thereof
MX369286B (en) Oral care compositions.
NZ733747A (en) Kdm1a inhibitors for the treatment of disease
EA202190368A1 (en) MODIFIED PLANT MESSENGER PACKAGES AND OPTIONS FOR THEIR APPLICATION
MY176900A (en) Antimicrobial compounds and methods of making and using the same
MX357903B (en) Antimicrobial compounds and methods of making and using the same.
MX2017016819A (en) Antimicrobial compositions and uses thereof.
IN2014CN04034A (en)
WO2013078259A3 (en) Oil compositions and methods for increasing hair growth and/or preventing hair loss
ATE474585T1 (en) PROBIOTIC ENTEROCOCCIES FOR IMPROVED IMMUNITY
WO2016108045A3 (en) Antimicrobial compounds, compositions and methods
NZ706636A (en) Probiotic and prebiotic compositions
MX2015012379A (en) Novel lactobacillus strains and the uses thereof.
UA111464C2 (en) The composition containing c1-c7 and glycerin, and its use as antibacterial and inhibiting agent
CY1118832T1 (en) MULTIPLE DOUBLE GEL FOR VINCIAL DRYING WITH IMMEDIATE AND REDUCED EFFECT
MX354047B (en) SPRAY-DRIED <i>LACTOBACILLUS</i> STEMS / CELLS AND THE USE OF SAME AGAINST <i>HELICOBACTER PYLORI.
WO2016191389A3 (en) Compositions containing antimicrobial igy antibodies, for treatment and prevention of disorders and diseases caused by oral health compromising (ohc) microorganisms
PH12017500708A1 (en) Probiotic and prebiotic compositions
WO2015143295A3 (en) Hydrogel toxin-absorbing or binding nanoparticles
MX368153B (en) PHARMACEUTICAL COMPOSITIONS and TREATMENT OF MASTITIS.
PH12014502243B1 (en) Novel bacillus subtilis
BR112018067860A2 (en) directly fed microbes
MX2013012574A (en) Palatability enhancing compositions.
EP4302825A3 (en) Pharmaceutical compositions for treatment of inappetence

Legal Events

Date Code Title Description
FG Grant or registration